Ghost Tree Capital’s Karuna Therapeutics KRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KRTX
Ghost Tree Capital's KRTX Position: Q4 2023 in Review
Ghost Tree Capital sold out of Karuna Therapeutics (KRTX) in Q4 2023, closing a stake of 12,500 shares — an estimated $2.11M sold.
Ghost Tree Capital first reported a position in KRTX in Q1 2022 and held it in 7 quarters. The position peaked at $7.86M in Q4 2022. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.
- Ghost Tree Capital reported no remaining Karuna Therapeutics position as of Q4 2023 after selling out during the quarter.
- Ghost Tree Capital sold 12,500 Karuna Therapeutics shares in Q4 2023, an estimated $2.11M.
- Ghost Tree Capital first reported a position in Karuna Therapeutics in Q1 2022 and held it in 7 quarters.
- Ghost Tree Capital's Karuna Therapeutics position peaked at $7.86M in Q4 2022.
- 328 funds tracked by Wall St. Rank held Karuna Therapeutics as of Q4 2023.
Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.